Medleaf Therapeutics – Life, made better.

Medleaf Therapeutics is Veridion Group’s dedicated medicinal cannabis brand, delivering high-quality, plant-based therapeutics designed to ease discomfort and improve quality of life.

Our mission grew from a simple truth: we could be doing better. Witnessing the positive impact of medicinal cannabis on patients – and the barriers they faced in accessing it – drove us to create a brand built on accessibility, quality, and care.

Medleaf Therapeutics products are crafted to help restore comfort and freedom of choice for patients, while our ongoing commitment to innovation ensures we continue to meet the evolving needs of healthcare professionals.

Medleaf Therapeutics offers the largest portfolio of medicinal cannabis cultivars currently available in New Zealand, with a range of potencies and therapeutic effects suitable for most patients. All flower products are non-irradiated and supplied in larger 30g units, providing improved value and flexibility for both patients and prescribers.

Demonstrating a focus on both quality and user experience, Medleaf Therapeutics was the first in New Zealand to introduce moisture control sachets as standard – ensuring freshness and consistency from packaging to patient.

At Medleaf, we believe in a future where natural therapies stand alongside modern
medicine – empowering people to live well.

Bloom – Sun-grown cannabis experts.

Bloom is Veridion Group’s trusted medicinal cannabis brand, dedicated to providing clinicians with high-quality, sun-grown cultivars designed to meet the diverse therapeutic needs of patients.

With a strong presence in regulated international markets, Bloom brings years of experience and expertise to New Zealand’s medicinal cannabis sector, offering consistent and reliable products that clinicians can confidently prescribe.

Our cultivars are carefully selected for their proven therapeutic effects, with an emphasis on quality, consistency, and efficacy. Each product is cultivated using sustainable, sun-grown practices to ensure the highest standards of safety and performance. Bloom’s focus on plant-based solutions supports a wide range of medical conditions, with clear product identification and straightforward selection to simplify the prescribing process.

Backed by a commitment to education, patient success, and evidence-based results, Bloom empowers clinicians to make informed prescribing decisions that align with patient needs. With a track record of success in established markets, Bloom is a trusted source for cannabis that prioritises patient well-being and clinical outcomes.

Curaleaf – Beyond the bud.

Curaleaf is an established leader in medicinal cannabis, dedicated to offering patients thoughtfully crafted, lab-tested products designed to meet a wide range of therapeutic needs. As part of Veridion Group’s brand portfolio, Curaleaf products are now exclusively available to the New Zealand market, bringing globally trusted quality to local prescribers and patients.

Curaleaf is the largest vertically integrated medicinal cannabis company in the world, with operations in over a dozen countries and an extensive track record of regulatory compliance. The brand is currently in active use in multiple highly regulated medical markets — including the United Kingdom, Australia, Ukraine, Germany, and Poland.

At Curaleaf, we believe cannabis care should be personal, precise, and approachable. With a strong commitment to product consistency and safety, we offer a diverse range of formats, cultivars, and cannabinoid profiles — allowing clinicians to confidently match patients with the product that best supports their health and wellbeing.

Beyond cultivation and product innovation, Curaleaf has built its reputation on education, research, and community care. From guiding first-time patients through their therapeutic options to supporting ongoing advocacy for safe, effective cannabis access, Curaleaf continues to shape the future of patient-focused cannabis worldwide.

Now available in New Zealand, Curaleaf represents more than a product – it’s a partnership in patient care.

Verileaf – Full-spectrum intelligence, education and care.

Verileaf is an Integrated Dual Intelligence Hub – a cohesive, intelligent ecosystem that unites advanced technology, expert clinical support, and patient-focused educational resources into one seamless platform. At its core the Verileaf Empower Prescribing Tool developed to equip clinicians with the confidence and intelligence required for evidence-based medicinal cannabis prescribing. In parallel, patients are supported with Verileaf Educare – clear, accessible knowledge and real-world tools to guide safe and effective treatment. Purpose-built to serve both clinicians and patients across the full spectrum of cannabis care, Verileaf sets a new standard in integrated, outcomes-driven healthcare.

Verileaf Empower – Precision prescribing intelligence.

Verileaf Empower features the Verileaf Prescribing Tool, an innovative, evidence-based solution for precision prescribing in medicinal cannabis. Clinicians can access cannabinoid and terpene profiles, dosing strategies, and condition-specific recommendations to support confident, data-driven decisions. With clinical education embedded throughout, Verileaf Empower transforms complex prescribing into structured, supported care – backed by the latest science and practical guidance.

Verileaf Empower enables clinicians to:

• Compare chemovars and match to symptom clusters
• Navigate cannabinoid and terpene profiles with clarity
• Tailor dosing by format, frequency, and patient type (naïve, polypharmacy, chronic)
• Justify treatment decisions with published evidence

Whether you’re new to prescribing cannabis or an experienced clinician, Verileaf Empower provides the tools and insights to enhance patient outcomes and elevate your practice.

Clinicians can access Verileaf Empower here.

Verileaf Educare – Enlighten. Engaged. Enriched.

Verileaf Educare is a trusted, clinician-aligned patient portal that empowers patients with the tools, education, and ongoing support needed to manage their medicinal cannabis treatment safely and effectively.

Designed to extend care beyond the consultation, Verileaf Educare supports a true continuum of care – aligning with clinical guidance while fostering patient understanding and confidence at every step.

With Verileaf Educare, patients can:

• Learn how to use medicinal cannabis safely, including vapourisation techniques and dose timing and tolerance breaks.
• Understand cannabinoid and terpene profiles in plain language
• Receive guidance on safe driving timeframes and daily functioning, including access to interactive tools that help assess potential impairment in real time
• Understand their legal rights regarding the prescription, possession, and use of controlled medicines, including safe storage, consumption, and carrying guidelines
• Explore wellbeing tools and lifestyle resources to enhance treatment outcomes

Whether accessed independently or through a referral from their clinician, Verileaf Educare ensures patients are informed, engaged, and supported throughout their medicinal cannabis journey.

Access Verileaf Educare here.

Grenco Medical – Advanced vapourisation, made accessible.

Grenco Medical is a global leader in vapourisation technology, providing medically approved devices designed specifically for the safe and effective delivery of medicinal cannabis flower.

Exclusively available in New Zealand through Veridion Group, Grenco Medical devices offer clinicians and patients an alternative to existing high-cost options – delivering the same rigorous safety, quality, and reliability, at a more accessible price point.

Backed by over a decade of engineering expertise, Grenco Medical combines advanced heating technology with precision design, ensuring each device supports both therapeutic integrity and user-friendly operation.

Designed for real-world clinical use, Grenco Medical’s vaporisers are built to meet the growing demand for reliable, efficient, and patient-friendly medicinal cannabis delivery systems in New Zealand’s regulated market.